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Abstract
Background Patients admitted to hospital with heart failure will have had a chest X-ray (CXR), but little is known about 
their prognostic significance. We aimed to report the prevalence and prognostic value of the initial chest radiograph findings 
in patients admitted to hospital with heart failure (acute heart failure, AHF).
Methods The erect CXRs of all patients admitted with AHF between October 2012 and November 2016 were reviewed for 
pulmonary venous congestion, Kerley B lines, pleural effusions and alveolar oedema. Film projection (whether anterior–poste-
rior [AP] or posterior–anterior [PA]) and cardiothoracic ratio (CTR) were also recorded. Trial registration: ISRCTN96643197
Results Of 1145 patients enrolled, 975 [median (interquartile range) age 77 (68–83) years, 61% with moderate, or worse, 
left ventricular systolic dysfunction, and median NT-proBNP 5047 (2337–10,945) ng/l] had an adequate initial radiograph, 
of which 691 (71%) were AP. The median CTR was 0.57 (IQR 0.53–0.61) in PA films and 0.60 (0.55–0.64) in AP films. 
Pulmonary venous congestion was present in 756 (78%) of films, Kerley B lines in 688 (71%), pleural effusions in 649 (67%) 
and alveolar oedema in 622 (64%).
A CXR score was constructed using the above features. Increasing score was associated with increasing age, urea, NT-
proBNP, and decreasing systolic blood pressure, haemoglobin and albumin; and with all-cause mortality on multivariable 
analysis (hazard ratio 1.10, 95% confidence intervals 1.07–1.13, p < 0.001).
Conclusions Radiographic evidence of congestion on a CXR is very common in patients with AHF and is associated with 
other clinical measures of worse prognosis.
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Graphic abstract
Signs of heart failure are highly prevalent in patients presenting to hospital with acute heart failure and when combined into a chest x-ray score, 
relate to a worse long term risk of death
Keywords Chest radiograph · Acute heart failure · Mortality · Congestion
Introduction
Heart failure (HF) is the leading cause of hospital admission 
in people aged 65 years or older in developed countries [1]. 
The chest X-ray (CXR) is one of the core investigations of 
breathless patients [2, 3]. In 1917, Danzer first identified car-
diomegaly as a possible indicator of left ventricular dilation 
[4]. As hydrostatic pressure increases in the lungs, signs of 
pulmonary congestion start to appear—pulmonary venous 
congestion, interstitial oedema, alveolar oedema and pleural 
effusions—that are often used as entry criteria in trials of 
therapies for patients presenting with acute HF [5, 6].
The CXR is not a diagnostic test for HF. There is little 
relation between cardiothoracic ratio (CTR) and left ventric-
ular systolic function [7]. Not all patients with acute HF have 
pulmonary congestion on their CXR [8]. However, amongst 
patients presenting to hospital with acute myocardial infarc-
tion, worsening features of HF on the CXR are related to 
increasing risk of death [9–13].
Fifty years ago, when rheumatic heart disease was 
common, acute pulmonary oedema was dramatic and life 
threatening [14]. Today, most patients admitted to hospital 
with HF no longer have new acute pulmonary oedema but 
instead present with decompensation of chronic underlying 
ventricular dysfunction, as a consequence of gradual but pro-
gressive increases in cardiac filling pressures [15, 16]. We, 
therefore, described the appearance of the initial CXR in a 
modern cohort of patients hospitalised for HF and assessed 
the relation between CXR appearance and outcome. We 
constructed a CXR scoring system and assessed the rela-




The observational study to predict readmission for heart 
failure patients (OPERA-HF) is a prospective observational 
study which enrolled patients hospitalised for HF in the Hull 
University Hospitals NHS Trust, UK. Patients had to fulfil 
the following criteria to be included: age > 18 years; usual 
residence in the region served by the Hull University Hospi-
tals NHS Trust; hospitalisation with HF; treatment with loop 
diuretics; and at least one of the following; left ventricu-
lar ejection fraction ≤ 40%; left atrial dimension ≥ 4.0 cm 
[17], or N-terminal pro-B-type natriuretic peptide (NT-
proBNP) > 400 pg/mL (if in sinus rhythm) or > 1200 pg/mL 
(if in atrial fibrillation—AF) [18]. Patients who were unable 
to understand and comply with the protocol or unable or 
unwilling to give informed consent were not included in the 
study.
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Chest radiography
The flow of patients through the study is shown in Fig. 1. 
The position (supine or erect) and projection of each film is 
written physically on the X-ray. In the present analysis, we 
included all patients who had an erect chest radiograph. The 
patient’s first radiograph on admission was reviewed. We 
excluded patients who had had only a supine film (as fluid in 
the lungs and pleura might have been distributed differently) 
or in whom the film was too rotated for interpretation. One 
investigator (Daniel Pan, DP) retrospectively reviewed all 
CXRs, grading the presence and severity of potential fea-
tures of HF, blind to all other clinical data.
The approach to grading the CXR is illustrated in Fig. 2. 
The following were recorded for each patient:
• The film projection—whether posterior–anterior (PA) or 
anterior–posterior (AP);
• Alveolar oedema—graded as absent, present (oedema 
covering any of the lungs, but not all zones in both lungs) 
or severe (oedema covering all zones in both lungs).
• Kerley B lines—graded as the presence or absence of 
prominent interstitial fissure lines in and between the 
lung lobes.
• Pleural effusions—graded as present or not present. 
Presence is when there are both costophrenic and car-
diophrenic blunting of one lung field.
• Pulmonary venous congestion—graded as present or 
absent. Presence is when there is an increase in the pro-
portion of vessels in the upper lung zones compared to 
the lower lung zones.
• Heart size—measured as CTR.
The CTR was calculated using the original method 
described by Danzer [4]. A single line is drawn dividing the 
cardiac silhouette vertically through the midline. Measure-
ment ‘A’ is widest point from the right heart border to the 
line; measurement ‘B’ is the widest point from the left heart 
border to the line. Measurement ‘C’ is the widest measure-
ment from the midline to the inner borders of the ribs. Thus, 
the CTR is defined as (A + B)/2C. An unmeasurable CTR 
was recorded where the cardiac borders were too obscure 
for accurate measurement. Although modern dictum sug-
gests that accurate CTR interpretation is not possible in AP 
films, we considered a CTR of > 0.55 to be cardiomegaly 
regardless of projection, in keeping with the previous lit-
erature [19].
Signs related to other pathology as routinely reported by 
the radiologist were also recorded. To assess repeatability 
of findings, 25 CXRs were randomly selected and scored by 
a second investigator (Shirley Sze, SS).
Patients were followed until 1st of May 2017; the main 
outcome of interest was all-cause mortality.
The study had ethical approval from the South Yorkshire 
Research Ethics Committee (REC ref: 12/YH/0344) and 
is conducted in accordance with ICH-GCP, Declaration of 
Helsinki, the Data Protection Act 1998 and NHS Act 2006.
Statistical analysis
Continuous variables are expressed as median and inter-
quartile range (IQR). Variables that were not normally 
distributed were log-transformed before analysis in further 
models. Categorical variables are expressed as numbers and 
percentages (%). Missing data were excluded from statisti-
cal analysis. Pearson’s Chi-squared test and Fisher’s exact 
row test were used to compare categorical variables between 
groups. Student’s t test and the Kruskal–Wallis test were 
used to compare continuous variables between the groups 
depending on the normality of the distribution.
Fig. 1  Flowchart illustrating the flow of patients through the study. 
CXR chest X-ray, CT computed tomography
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Several Cox proportional hazard regression models 
were used to investigate the relation between variables 
and all-cause mortality. A first model was used to assign 
a weighting to the CXR variables based on their relation 
to prognosis. Only CXR variables were included in this 
model. Those significantly related to mortality on univari-
able analysis (a liberal threshold of P < 0.10 was used) 
were chosen for the multivariable model. The assigned 
points of the CXR score were generated by the beta coef-
ficient (log hazard ratio) for each variable from the mul-
tivariable analysis, multiplied by ten and rounded to the 
nearest whole number [20].
A base model was constructed to assess the incremental 
value of the new CXR score in addition to other important 
clinical variables in predicting mortality. The base model 
included variables which had few missing data (< 1%) and 
which were also significantly related to mortality on univari-
able Cox regression analysis (again, a liberal threshold of 
P < 0.10 was used).
The individual CXR variables and the CXR score were 
then added to the base model, separately and in combina-
tion, to the find the best model to predict mortality. The 
new models’ cumulative discrimination was measured using 
Harrell’s C statistic; its statistical significance in comparison 
to the base model was assessed with the likelihood ratio 
test. A 2-sided P value ≤ 0.05 was considered statistically 
significant.
Venn diagrams are used to illustrate the relation between 
different features of pulmonary congestion. Kaplan–Meier 
curves, censored at 4 years, with the log-rank statistic were 
used to illustrate outcome.
Repeatability of CXR findings was tested using weighted 
Cohen’s Kappa statistic and Bland–Altman plots [21].
All analyses were performed using STATA software (ver-
sion 14.2, StataCorp, Texas, United States) and Excel ver-
sion 2016 (Microsoft, Redmond, United States).
Results
Participants
Between October 2012 and November 2016, 1145 patients 
were enrolled into OPERA-HF. After excluding 70 patients 
because they did not have a CXR during admission and 
another 100 patients because the CXRs were inadequate for 
interpretation, 975 remained (Fig. 1).
Table 1 shows the clinical and laboratory findings of 
patients recruited into the study on admission to hospital. 
Most patients had been hospitalised for HF in the previ-
ous year (60%). A quarter (26%) of patients did not have 
NT-proBNP measured on admission. Half of patients 
(54%) presented with breathlessness on exertion; 26% with 
breathlessness at rest and in the remainder, a symptom other 
Fig. 2  Illustration demonstrating how chest X-ray features of heart failure was identified
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than breathlessness was the reason for admission. 11% of 
patients presented with HF associated with an acute coro-
nary syndrome.
Chest radiography appearances
Table 2 shows the CXR appearances of patients in the 
study. Most patients had AP CXRs (71%,). There was a low 
prevalence of features on the CXR unrelated to HF, includ-
ing: consolidation (N = 91); pulmonary fibrosis (N = 16); 
hiatus hernia (N = 3); tumours/nodules (N = 7); pulmonary 
infarction (N = 5); pulmonary plaques (N = 13) and pneu-
monectomy (N = 1).
Cardiomegaly was present in 67% and un-measureable in 
6%. The median CTR (excluding those in whom a measure-
ment was not possible, N = 55) was 0.57 (IQR 0.53–0.61) 
Table 1  Clinical and laboratory 
findings of patients recruited 
into the study on admission to 
hospital
28 patients had missing electrocardiograms because they could not be found in the clinical notes, 64 
patients had missing echocardiograms because they had died before the investigation could be performed 
and 3 serum potassiums were missing because the blood samples had haemolysed
QRS duration–duration of QRS complex on electrocardiogram
NT-proBNP N-terminal-pro brain natriuretic peptide




 Age—years 77 (68–83) 0
 Males 598 (61%)
 Hosp. for heart failure in the previous year 581 (60%)
 Prior myocardial infarction 220 (23%)
 Prior coronary artery bypass graft 136 (14%)
 Malignancy 108 (11%)
 Diabetes 323 (33%)
 Chronic obstructive pulmonary disease 160 (16%)
 ACS on admission for heart failure 101 (11%)
 Systolic blood pressure—mmHg 129 (114–147)
 Diastolic blood pressure—mmHg 74 (62–86)
Main presenting symptom
 Breathlessness at rest 257 (26%) 0
 Worsening breathlessness on exertion 529 (54%)
 Breathlessness not a main presenting symptom 189 (19%)
Findings on electrocardiogram
 Atrial fibrillation 460 (47%) 28
 QRS duration—milliseconds 104 (91–136)
 Heart rate—beats per minute 91 (73–112)











 Sodium—mmol/L 137 (134–139) 0
 Potassium—mmol/L 4.3 (4.0–4.7) 3
 Urea—mmol/L 8.7 (6.2–13.0) 0
 Creatinine—µmol/L 104 (82–144) 0
 Troponin T—ng/ml 50 (29–148) 542
 NT-proBNP—pg/ml 5047 (2337–10,945) 253
 Haemoglobin—mmol/L 125 (110–139) 0
 Chloride—mmol/L 101 (98–105)
 Albumin—mmol/L 34 (31–37) 2
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in those with PA films and 0.60 (IQR 0.55–0.64) in those 
with AP films. Pulmonary venous congestion was present in 
78%, and a degree of alveolar oedema was present in 64% 
(although only 10% had severe alveolar oedema). Only one 
film had a pleural effusion that covered most of one lung 
field.
Figure 3 illustrates the percentage of patients with dif-
ferent features of pulmonary congestion. A third (33%) 
of patients had all four features of pulmonary congestion 
(Fig. 3); only 5% had none and 10% had only one. Features 
of pulmonary congestion were generally more common with 
increasing CTR and on AP compared to PA films as shown 
by the bar charts illustrating the proportion of patients with 
each feature of pulmonary congestion, by cardiothoracic 
ratio and chest X-ray projection in Fig. 4.
Generation of the CXR score, relation to clinical 
variables and relation to outcome
After a median follow-up of 671 days, 440 (45%) patients 
had died of which 41 died during the index admission. A 
fifth (19%) of the patients was readmitted with worsening HF 
within 30 days of discharge from their index hospitalisation.
Table 3 shows Cox regression analyses of chest X-ray var-
iables and formation of the chest X-ray score; Fig. 5 shows 
Kaplan–Meier curves of all-cause mortality for chest X-ray 
projection, cardiothoracic ratio, pleural effusion, alveolar 
oedema. In univariable Cox regression analysis, each radio-
logical abnormality, except pulmonary venous congestion, 
was associated with all-cause mortality. Consequently, a 
score was constructed using all CXR signs apart from pul-
monary venous congestion.
Table 4 shows clinical and laboratory findings of patients 
recruited into the study and in-hospital mortality, 30-day 
mortality and readmission to hospital within 30 days of dis-
charge by increasing chest X-ray score. There was no rela-
tion between the CXR score and the presence (or absence) 
of left ventricular systolic dysfunction. Although associ-
ated with all-cause mortality at 4 years, the CXR score was 
neither associated with in-hospital mortality, nor mortality 
or readmission within 30 days of discharge. A worsening 
CXR score was associated with older age, higher serum 
Table 2  Radiological findings of patients recruited into the study on 
admission, and in-hospital mortality, 30-day mortality and readmis-
sion to hospital within 30 days of discharge
Variables Patients
Chest X-ray findings
 Cardiothoracic ratio (≤ 0.55) 261 (27%)
 Cardiothoracic ratio (0.55–0.70) 606 (62%)
 Cardiothoracic ratio (> 0.70) 53 (5%)
 Cardiothoracic ratio: unmeasurable 55 (6%)
 Cardiothoracic ratio 0.59 (0.55–0.64)
 Film projection—anterior–posterior 691 (71%)
 Cardiothoracic ratio (posterior-anterior films) 0.57 (0.53–0.61)
 Cardiothoracic ratio (anterior–posterior films) 0.60 (0.55–0.64)
 Moderate alveolar oedema 525 (54%)
 Severe alveolar oedema 97 (10%)
 Kerley B lines 688 (71%)
 Pleural effusion 649 (67%)
 Pulmonary venous congestion 756 (78%)
Outcomes n = (%)
 In-hospital mortality 41 (4%)
 30-day mortality 44 (5%)
 Readmission to hospital within 30-days of 
discharge
181 (19%)
 All-cause mortality at end of follow-up 440 (45%)
Fig. 3  Venn diagram illustrat-
ing percentage of patients with 
different features of pulmonary 
congestion
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concentrations of potassium and urea and higher plasma 
NT-proBNP (especially if the patient was in AF), lower val-
ues for diastolic blood pressure, haemoglobin, and albumin, 
being a woman, prior CABG and presenting with breathless-
ness as the main symptom.
CXR scores were lower in the 5% of patients (n = 49) 
whose first radiograph was taken more than 24 h after admis-
sion than in those who had their CXR earlier [median score 
3 (IQR 3–7) v 7 (5–9), P < 0.001].
Relation of the CXR score to prognosis in addition 
to other variables
Tables 5 and 6 show univariable and multivariable Cox regres-
sion analyses of clinical and laboratory variables and the chest 
X-ray score On univariable Cox regression analysis, age, gen-
der, hospitalisation for heart failure in the previous year, prior 
MI or CABG, malignancy, lower systolic and diastolic blood 
pressures, lower heart rate, lower sodium, haemoglobin, chlo-
ride and albumin and higher potassium, renal function, tro-
ponin, and NT-proBNP, and a higher CXR score was related 
to mortality. In a multivariable model, older age and higher 
serum concentrations of urea and sodium, lower systolic blood 
pressure, lower heart rate and lower serum concentrations of 
chloride and albumin were independent predictors of mortal-
ity. The CXR score was also independently associated with 
mortality (HR 1.10, 95% CI 1.07–1.13 per point increase, 
P < 0.001). However, CXR score did not improve the model’s 
c-statistic for predicting mortality at different time-points as 
shown in Table 7.
Reproducibility
CXR variables varied in reliability, with alveolar oedema 
being the most reliable and CTR being the least, as shown in 
Table 7.
Fig. 4  Bar charts illustrating proportion of patients with each feature of pulmonary congestion, by cardiothoracic ratio and chest X-ray projec-
tion. Pearson’s Chi-squared test was used
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Discussion
There are three main findings from this study. First, radio-
logical evidence of congestion is very common in patients 
presenting to hospital with HF. Second, patients present-
ing with breathlessness as their dominant symptom have a 
higher CXR score. Third, increasing pulmonary congestion 
on the CXR score is related to worsening HF as assessed 
by other clinical measures such as age, potassium, urea, 
NT-proBNP, haemoglobin and albumin, and is associated 
with increasing all-cause mortality, but not related to overall 
prognosis when these other variables are taken into account.
We found that the commonest abnormal feature on the 
chest X-ray was venous congestion, presumably representing 
a rise in left atrial pressure. As heart failure worsens, fluid 
can escape from pulmonary capillaries into the interstitial 
and pleural spaces resulting in Kerley B lines and pleural 
effusions, the next two most common features we found. 
Frank alveolar oedema was the least common finding, and 
represents the patient passing a ‘tipping point’ when the 
capacity of the lymphatics to remove fluid is exceeded and 
fluid starts to accumulate in the airspaces of the lungs [16].
Previous older studies have graded congestion in an incre-
mental fashion based on the aforementioned sequence of 
events, with stage one being pulmonary venous congestion, 
stage two interstitial oedema and stage three alveolar oedema 
[11–13, 22]. We chose to grade all features separately and 
found that although many had pulmonary venous conges-
tion and few had severe alveolar oedema, patients commonly 
have features of pulmonary congestion not in sequence. It 
may be that if pulmonary congestion happens very rapidly, 
the radiographic features might not occur in order.
Our study findings confirm that the CXR can identify 
pulmonary congestion as a potential cause of breathlessness 
in patients presenting to hospital. Since congestion on the 
CXR is still related to mortality in HF patients on univari-
able analysis, this should prompt clinicians to adequately 
diurese the patient when necessary.
Only a small proportion of patients (91/975, 9%) in our 
cohort had evidence of pneumonia on the CXR. Future 
studies should investigate whether the CXR can help to 
differentiate pulmonary congestion from other causes of 
breathlessness, and influence therapeutic decision making 
beyond HF, such as the initiation of antibiotics. The CXR 
Table 3  Univariable and multivariable Cox regression analyses of chest X-ray variables and formation of the chest X-ray score
The score was constructed using the beta-coefficients (log hazard ratio) of a multivariable model, containing only chest X-ray variables that 
were significantly related to all-cause mortality on univariable analysis (p < 0.1). These variables were: alveolar oedema, Kerley B lines, cardio-
thoracic ratio, chest X-ray projection and pleural effusions. For example, the beta coefficient for Kerley B lines from the multivariate analysis is 
0.19—which was rounded to 0.2 multiplied by 100 to give 2 points
CI confidence intervals, N/A not applicable
Outcome: all-cause mortality Hazard ratio (95% CI) Wald X2 P value Hazard ratio (95% CI) β-coefficient Score
Alveolar oedema
 Absent Referent Referent Referent Referent Referent 0
 Present 1.20 (0.98–1.47) 1.71 0.09 1.04 (0.84–1.31) 0.05 1
 Severe 1.67 (1.22–2.28) 3.20 0.001 1.35 (0.97–1.88) 0.30 3
Kerley B lines
 Absent Referent Referent Referent Referent Referent 0
 Present 1.28 (1.04–1.59) 2.30 0.02 1.21 (0.98–1.51) 0.19 2
 Cardiothoracic ratio
 ≤ 0.55 Referent Referent Referent Referent Referent 0
 0.55–0.70 1.21 (0.96–1.52) 1.62 0.10 1.12 (0.89–1.41) 0.12 1
 > 0.70/unmeasurable 1.84 (1.35–2.50) 3.84  < 0.001 1.60 (1.16–2.19) 0.46 5
Chest X-ray projection
 Posterior-anterior Referent Referent Referent Referent Referent 0
 Anterior–posterior 1.13 (1.07–1.20) 4.28  < 0.001 1.47 (1.17–1.86) 0.38 4
Pleural effusions
 Absent Referent Referent Referent Referent Referent 0
 Present 1.29 (1.05–1.59) 2.47 0.01 1.12 (0.89–1.40) 0.11 1
Pulmonary venous congestion
 Absent Referent Referent Referent N/A N/A N/A
 Present 1.06 (0.85–1.33) 0.53 0.60 N/A N/A N/A
Chest X-ray score
 Chest X-ray score 1.10 (1.07–1.13) 6.15  < 0.001 N/A N/A N/A
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remains a source of important clinical information and 
may be used within artificial intelligence algorithms, to 
help assist clinicians improve the diagnosis of AHF and 
guide management [23].
To our knowledge, this is the first study which has 
found a relation between CXR projection and all-cause 
mortality. If a patient is too unwell to stand, inhale and 
hold their breath, then an AP film in the sitting upright 
position is performed [24], and thus projection is a marker 
of a patient’s fitness during their acute illness.
Our findings agree with previous work, which found 
that cardiomegaly on the CXR, regardless of projection, 
was related to a worse prognosis in patients with acute and 
chronic HF [9, 10]. However, despite a high level of read-
mission to hospital within 30 days of discharge, in-hospital 
and 30-day mortality was low. None of these outcomes 
Fig. 5  Kaplan–Meier curves of all-cause mortality for chest X-ray projection, cardiothoracic ratio, pleural effusion, alveolar oedema, Kerley B 
lines and the chest X-ray score. AP anterior–posterior, PA posterior–anterior, HF heart failure
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Table 4  Clinical and laboratory findings of patients recruited into the study and in-hospital mortality, 30-day mortality and readmission to hospi-
tal within 30 days of discharge by increasing chest X-ray score
QRS duration–duration of QRS complex on electrocardiogram, NT-proBNP N-terminal-pro brain natriuretic peptide
Continuous variables are displayed as median (interquartile range) and categorical variables are displayed as number (percentage). For categori-
cal variables, Pearson’s Chi-squared test was used. If variables did not fit the assumptions of the Pearson’s Chi-squared test, Fisher’s exact test 
was used (labelled with *). For continuous variables, student’s t test and ANOVA was used to compare variables that were normally distributed 
Variables Chest X-ray score P value
Demographics
 Chest X-ray score N = 975 0
N = 22 (2%)
1–4
N = 200 (20%)
5–8
N = 288 (30%)
 > 8
N = 465 (48%)
 Age—years 74 (67–78) 73 (64–80) 76 (67–83) 78 (71–85)  < 0.001
 Men 15 (68%) 148 (74%) 176 (61%) 259 (56%)  < 0.001
 Hosp. for heart failure in the previous year 13 (59%) 111 (56%) 180 (63%) 277 (60%) 0.49
 Prior myocardial infarction 6 (27%) 40 (20%) 64 (22%) 110 (24%) 0.71
 Prior coronary artery bypass graft 7 (32%) 35 (18%) 39 (14%) 55 (12%) 0.02
 Malignancy 3 (14%) 15 (8%) 36 (13%) 54 (12%) 0.27*
 Diabetes 5 (23%) 57 (29%) 105 (36%) 156 (34%) 0.21*
 Chronic obstructive pulmonary disease 4 (18%) 27 (14%) 41 (14%) 88 (19%) 0.22*
 ACS on admission for heart failure 4 (18%) 12 (6%) 33 (12%) 52 (12%) 0.10*
 Systolic blood pressure—mmHg 139 (113–154) 130 (115–146) 128 (116–150) 129 (112–145) 0.50
 Diastolic blood pressure—mmHg 78 (65–86) 79 (65–89) 74 (63–87) 71 (62–85) 0.01
Breathlessness at presentation
 Not the main complaint 10 (46%) 34 (17%) 61 (21%) 84 (18%) 0.04*
 Worsening on exertion 11 (50%) 113 (57%) 155 (54%) 250 (54%)
 Severe at rest 1 (5%) 53 (27%) 72 (25%) 131 (28%)
ECG findings
 Atrial fibrillation 9 (41%) 98 (49%) 128 (44%) 225 (48%) 0.63
 QRS duration—milliseconds 122 (34%) 113 (39%) 111 (33%) 118 (45%) 0.09
 Heart rate—beats/minute 87 (25%) 93 (27%) 95 (31%) 96 (28%) 0.38
Left ventricular systolic dysfunction
 None—mild 8 (38%) 70 (36%) 97 (36%) 183 (43%) 0.21
 Moderate—severe 13 (62%) 123 (64%) 174 (64%) 243 (57%)
Blood tests
 Sodium—mmol/L 137 (135–139) 137 (134–139) 137 (134–139) 137 (134–139) 0.83
 Potassium—mmol/L 4.3 (4.0–4.4) 4.3 (4.0–4.5) 4.3 (4.0–4.6) 4.4 (4.0–4.9) 0.02


















































 Haemoglobin—mmol/L 136 (123–142) 130 (116–143) 122 (109–139) 123 (108–137) 0.004
 Chloride—mmol/L 103 (100–105) 101 (98–105) 101 (98–105) 101 (97–105) 0.48
 Albumin—mmol/L 37 (34–39) 34 (32–38) 34 (31–37) 34 (31–37) 0.002
Outcomes
 In-hospital mortality 0 (0%) 6 (3%) 11 (4%) 24 (5%) 0.57*
 30-day mortality 0 (0%) 6 (3%) 13 (5%) 25 (5%) 0.52*
 Readmission within 30 days of discharge 3 (14%) 34 (17%) 56 (20%) 88 (19%) 0.87*
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strongly related to the degree of congestion, consistent 
with the observation that early readmissions are often 
not for HF [25–27]. Our CXR score was strongly related 
to clinical variables that are related to the prognosis of 
patients with acute HF. Thus, it is not surprising that CXR 
features do not add much to the predictive power of models 
that included these variables.
One surprising finding was that a lower initial heart rate 
was related to higher mortality. Lourenco and colleagues had 
similar findings amongst 564 patients presenting with acute 
and Kruskal–Wallis was used for variables that were not normally distributed (labelled with **)
Table 4  (continued)
Table 5  Univariable Cox regression analyses of clinical and laboratory variables and the chest X-ray score
Variables which were not normally distributed were log-transformed
QRS duration–duration of QRS complex on electrocardiogram, NT-proBNP N-terminal-pro brain natriuretic peptide, N/A not applicable
Outcome: all-cause mortality Univariable analysis
Hazard ratio (95% CI) Wald X2 P value
Demographics
 Age (per year increase) 1.05 (1.04–1.06) 10.30  < 0.001
 Gender (male vs female)
 Hosp. for heart failure in the previous year (yes vs no) 1.48 (1.21–1.80) 3.86  < 0.001
 Prior myocardial infarction (yes vs no) 1.41 (1.14–1.74) 3..22 0.001
 Prior coronary artery bypass graft (yes vs no) 1.55 (1.22–1.98) 3.52  < 0.001
 Malignancy (yes vs no) 1.35 (1.01–1.80) 2.06 0.04
 Diabetes (yes vs no) 1.19 (0.98–1.44) 1.74 0.08
 Chronic obstructive pulmonary disease (yes vs no)
 ACS on admission for heart failure
 Systolic blood pressure—mmHg (per 10 unit increase) 0.93 (0.89–0.97) – 3.71  < 0.001
 Diastolic blood pressure—mmHg (per 10 unit increase) 0.98 (0.97–0.98) – 7.29  < 0.001
Main presenting symptom
 Breathlessness not main presenting symptom Referent Referent Referent
 Worsening breathlessness on exertion 1.05 (0.83–1.35) 0.43 0.67
 Breathlessness at rest 0.82 (0.62–1.09) – 1.38 0.17
Findings on ECG
 Atrial fibrillation (yes vs no) 1.07 (0.89–1.29) 1.70 0.49
 QRS duration—milliseconds (per unit increase in log QRS duration) 1.13 (0.82–1.56) 0.75 0.45
 Heart rate—beats/second (per 10 unit increase) 0.92 (0.88–0.95) – 4.92  < 0.001
Left ventricular systolic dysfunction
 None or mild Referent Referent Referent
 Moderate or severe 0.78 (0.64–0.95) – 2.42 0.02
Blood tests
 Sodium—mmol/L (per unit increase) 0.97 (0.95–0.99) – 2.64 0.008
 Potassium—mmol/L (per unit increase) 1.20 (1.04–1.39) 2.51 0.01
 Urea—mmol/L (per unit increase in log urea) 2.35 (2.00–2.77) 10.26  < 0.001
 Creatinine—μmol/L (per unit increase in log creatinine) 2.33 (1.90–2.86) 8.06  < 0.001
 Troponin—ng/ml (per unit increase in log troponin) 1.17 (1.08–1.27) 3.68  < 0.001
 NT-proBNP—pg/ml (per unit increase in log NT-proBNP) 1.33 (1.20–1.48) 5.43  < 0.001
 Haemoglobin—mmol/L (per 10 unit increase) 0.88 (0.84–0.92) – 6.15  < 0.001
 Chloride—mmol/L (per 10 unit increase) 0.61 (0.51–0.73) – 5.49  < 0.001
 Albumin—mmol/L (per 10 unit increase) 0.60 (0.50–0.72) – 5.37  < 0.001
Chest X-ray score
 Chest X-ray score (per unit increase) 1.10 (1.07–1.13) 6.15  < 0.001
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HF to a single centre [28]. In both studies, the first heart 
rate measurement was recorded on presentation to hospital. 
Although a higher resting heart rate predicts higher mortal-
ity in chronic HF, a faster initial heart rate in acute HF may 
be a marker of a preserved autonomic nervous response.
Limitations
This is a single centre study. Most patients were of Cauca-
sian ethnicity. Notably, Kobayashi and colleagues recently 
examined pulmonary congestion on the CXR in 117 patients 
and found that a worsening congestion score index was asso-
ciated with a composite of all-cause mortality or rehospi-
talisation for HF at 90 days [29]. The index was generated 
from dividing the chest X-ray into six zones, and grading 
the severity of congestion in each lung zone. Our method 
of grading the CXR is far more likely to be the way CXRs 
are routinely examined in the UK. We have also taken into 
account radiograph projection or CTR, both of which we 
have shown to relate to worse prognosis.
Our version of the CXR score need to be validated in 
another population. Although reports from radiologists 
were used, no radiologists were involved in the retrospec-
tive review of the films. This may account for some of the 
variation in reproducibility of CXR variables and possibly 
misinterpretation of films, such as pneumonia being mis-
taken for localised alveolar oedema. However, diagnosis and 
treatment of HF is started as soon as the patient is admitted 
Table 6  Multivariable Cox regression analysis
Only variables significantly related to prognosis (p < 0.05) are displayed. Variables which were not normally distributed were log-transformed. 
The base model contains only variables that were significantly related to all-cause mortality on univariable analysis, displayed in Table 3
QRS duration–duration of QRS complex on electrocardiogram, NT-proBNP N-terminal-pro brain natriuretic peptide, N/A not applicable
Outcome: all-cause mortality Multivariable analysis (base model) Multivariable analysis (base model and 
chest X-ray score)
Hazard ratio (95% CI) Wald X2 P value Hazard ratio (95% CI) Wald X2 P value
Demographics
 Age (per year increase) 1.04 (1.03–1.05) 6.95  < 0.001 1.04 (1.03–1.05) 6.33  < 0.001
 Systolic blood pressure—mmHg (per 10 unit increase) 0.94 (0.89–0.99) − 2.52 0.01 0.94 (0.90–0.99) − 2.40 0.02
Findings on ECG
 Heart rate—beats/minute (per 10 unit increase) 0.95 (0.91–0.98) − 2.78 0.005 0.94 (0.90–0.97) -3.25 0.001
Blood tests
 Sodium—mmol/L (per unit increase) 1.05 (1.01–1.08) − 2.55 0.01 1.04 (1.01–1.08) 2.33 0.02
 Urea—mmol/L (per unit increase in log urea) 1.41 (1.01–1.98) 2.00 0.05 1.42 (1.01–1.99) 2.01 0.04
 Chloride—mmol/L (per 10 unit increase) 0.51 (0.38–0.67) − 4.69  < 0.001 0.51 (0.38–0.67) − 4.71  < 0.001
 Albumin—mmol/L (per 10 unit increase) 0.69 (0.54–0.88) − 3.03 0.002 0.71 (0.56–0.91) − 2.72 0.006
Chest X-ray score
 Chest X-ray score (per unit increase) N/A 1.07 (1.03–1.11) 3.75  < 0.001
Table 7  Reproducibility statistics (Cohen’s kappa for categorical 
variables and Bland Altman limits of agreement for continuous vari-
ables) got the chest X-ray variables and the chest X-ray score as well 
as the Harrell’s c-statistic and likelihood ratio tests of the multivari-
able Cox regression models
The base model contains variables displayed in Tables 5 and 6 and is the same base model used in this table
CI confidence intervals, N/A not applicable




Mortality (N, %) 1 month (38, 100%) 1 year (263, 80%) 3 years (409, 56%) 4 years (435, 48%)
Base model 0.84 0.72 0.70 0.71
  + B lines 0.55 (0.001) 0.84 (0.42) 0.72 (0.55) 0.70 (0.90) 0.71 (0.76)
  + Effusions 0.78 (< 0.001) 0.84 (0.90) 0.72 (0.14) 0.70 (0.39) 0.71 (0.83)
  + Oedema 0.82 (< 0.001) 0.85 (0.10) 0.72 (0.05) 0.70 (0.18) 0.71 (0.30)
  + CTR 0.53 (0.003) 0.84 (0.65) 0.72 (0.01) 0.70 (0.02) 0.71 (0.01)
  + Projection N/A 0.83 (0.51) 0.72 (0.01) 0.70 (0.19) 0.71 (0.05)
  + CXR score 0.40 (-1.90–2.67) 0.84 (0.77) 0.72 (< 0.001) 0.70 (0.01) 0.71 (0.006)
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to hospital and not usually after radiology consult. The Heart 
Failure Association of the European Society of Cardiology 
has published a position paper which recommends proper 
assessment of cardiomegaly, pulmonary venous conges-
tion, pleural effusions, interstitial and alveolar oedema by 
all admitting physicians [30]. This study, therefore, reflects 
how CXRs would be interpreted by the majority of clinicians 
treating patients presenting with breathlessness.
Most CXRs were done within the first 24 h of admission 
but the CXR scores of those who had their first film after 
24 h were lower. It is unknown which of these CXR appear-
ances were influenced by diuretic administration. In another 
study, Kobayashi and colleagues found that residual pulmo-
nary congestion on the CXR prior to discharge predicted a 
composite outcome of all-cause mortality or rehospitalisa-
tion for heart failure at 1 year [31].
Conclusions
In patients admitted to hospital for HF, there is a high prev-
alence of radiographic features of congestion. Worsening 
features of congestion are associated with variables related 
to worse prognosis. An increase in the CXR score is related 
to increasing all-cause mortality but is not an independent 
predictor of outcome when other variables are taken into 
account.
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